We tried to address some of these issues while working on an RNAi - based microbicide to prevent sexual transmission of viral infection (and ultimately HIV) in mice.
That $ 90 million study, financed by the U.S. National Institutes of Health (NIH), startled many in the field who, based on other failures of nonspecific microbicides, had predicted the product would do nothing.